Cytosine deaminase-producing human mesenchymal stem cells mediate an antitumor effect in a mouse xenograft model

Journal of Gastroenterology and Hepatology (Australia)

Volumn 24, Issue 8, 2009, Pages 1393-1400

  You, Mi Hyeon ^a   Kim, Wang Joon ^b   Shim, Wooyoung ^b   Lee, Sang Rim ^c   Lee, Gwang ^b   Choi, Sangdun ^b   Kim, Dae Yong ^a   Kim, Yong Man ^d   Kim, Hyunsoo ^d   Han, Sang Uk ^b,c  

^a Seoul National University   (South Korea)

^b Ajou University   (South Korea)

^c Ajou University School of Medicine   (South Korea)

^d FCB Pharmicell Co Ltd   (South Korea)

Author keywords

Cytosine deaminase; Gastric cancer; Gene therapy; Mesenchymal stem cell; Suicide effect

Indexed keywords

CYTOSINE DEAMINASE; FLUCYTOSINE; FLUORESCENT DYE; FLUOROURACIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW; CELL MIGRATION; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PRIORITY JOURNAL; STOMACH CANCER; TUMOR GROWTH; TUMOR VOLUME; TUMOR XENOGRAFT;

EID: 69049084617     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2009.05862.x     Document Type: Article

References (30)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 2005 55 : 74 108.
2. Kim HJ, Chang WK, Kim MK, Lee SS, Choi BY. Dietary factors and gastric cancer in Korea: a case-control study. Int. J. Cancer 2002 97 : 531 535.
3. Reiser J, Zhang XY, Hemenway CS, Mondal D, Pradhan L, La Russa VF. Potential of mesenchymal stem cells in gene therapy approaches for inherited and acquired diseases. Expert Opin. Biol. Ther. 2005 5 : 1571 1584.
4. Kucerova L, Altanerova V, Matuskova M, Tyciakova S, Altaner C. Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy. Cancer Res. 2007 67 : 6304 6313.
5. Kucerova L, Matuskova M, Pastorakova A et al. Cytosine deaminase expressing human mesenchymal stem cells mediated tumour regression in melanoma bearing mice. J. Gene. Med. 2008 10 : 1071 1082.
6. Studeny M, Marini FC, Champlin RE, Zompetta C, Fidler IJ, Andreeff M. Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res 2002 62 : 3603 3608.
7. Studeny M, Marini FC, Dembinski JL et al. Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J. Natl. Cancer Inst. 2004 96 : 1593 1603.
8. Huber BE, Austin EA, Good SS, Knick VC, Tibbels S, Richards CA. In-vivo antitumor-activity of 5-Fluorocytosine on human colorectal-carcinoma cells genetically-modified to express cytosine deaminase. Cancer Res. 1993 53 : 4619 4626.
9. Moolten FL. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes - paradigm for a prospective cancer control strategy. Cancer Res. 1986 46 : 5276 5281.
10. Gilula NB, Reeves OR, Steinbac A. Metabolic coupling, ionic coupling and cell contacts. Nature 1972 235 : 262 265.
11. Kato H, Koshida K, Yokoyama K, Mizokami A, Namiki M. Potential benefits of combining cytosine deaminase/5-fluorocytosine gene therapy and irradiation for prostate cancer: experimental study. Int. J. Urol. 2002 9 : 567 576.
12. Mullen CA, Coale MM, Lowe R, Blaese RM. Tumors expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5-fluorocytosine and induce protective immunity to wild type tumor. Cancer Res. 1994 54 : 1503 1506.
13. Spears CP, Gustavsson BG, Mitchell MS et al. Thymidylate synthetase inhibition in malignant tumors and normal liver of patients given intravenous 5-fluorouracil. Cancer Res. 1984 44 : 4144 4150.
14. Spears CP, Shahinian AH, Moran RG, Heidelberger C, Corbett TH. In vivo kinetics of thymidylate synthetase inhibition of 5-fluorouracil-sensitive and -resistant murine colon adenocarcinomas. Cancer Res. 1982 42 : 450 456.
15. Parker WB, Cheng YC. Metabolism and mechanism of action of 5-fluorouracil. Pharmacol. Ther. 1990 48 : 381 395.
16. Bang OY, Lee JS, Lee PH, Lee G. Autologous mesenchymal stem cell transplantation in stroke patients. Ann. Neurol. 2005 57 : 874 882.
17. Lee PH, Kim JW, Bang OY, Ahn YH, Joo IS, Huh K. Autologous mesenchymal stem cell therapy delays the progression of neurological deficits in patients with multiple system atrophy. Clin. Pharmacol. Ther. 2008 83 : 723 730.
18. Nakamizo A, Marini F, Amano T et al. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res. 2005 65 : 3307 3318.
19. Royet JP. Stereology: a method for analyzing images. Prog. Neurobiol. 1991 37 : 433 474.
20. Chang J, Park K, Bang YJ et al. Expression of transforming growth factor beta type II receptor reduces tumorigenicity in human gastric cancer cells. Cancer Res. 1997 : 57 : 2856 2859.
21. Studeny M, Marini FC, Dembinski JL, et al. Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J. Natl. Cancer Inst. 2004 96 : 1593 1603.
22. Hung SC, Deng WP, Yang WK et al. Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging. Clin. Cancer Res. 2005 11 : 7749 7756.
23. Crystal RG, Hirschowitz E, Lieberman M et al. Phase I study of direct administration of a replication deficient adenovirus vector containing the E. coli cytosine deaminase gene to metastatic colon carcinoma of the liver in association with the oral administration of the pro-drug 5-fluorocytosine. Hum. Gene. Ther. 1997 8 : 985 1001.
24. Sun SY, Hail N, Lotan R. Apoptosis as a novel target for cancer chemoprevention. J. Natl. Cancer Inst. 2004 96 : 662 672.
25. Bieback K, Kern S, Kluter H, Eichler H. Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells 2004 22 : 625 634.
26. Kim SK, Kim SU, Park IH et al. Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression. Clin. Cancer Res. 2006 12 : 5550 5556.
27. De Keyser J. Autologous mesenchymal stem cell transplantation in stroke patients. Ann. Neurol. 2005 58 : 653 654.
28. Djouad F, Plence P, Bony C et al. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 2003 102 : 3837 3844.
29. Sato T, Sakai T, Noguchi Y, Takita M, Hirakawa S, Ito A. Tumor-stromal cell contact promotes invasion of human uterine cervical carcinoma cells by augmenting the expression and activation of stromal matrix metalloproteinases. Gynecol. Oncol. 2004 92 : 47 56.
30. Wagner W, Wein F, Seckinger A et al. Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp. Hematol. 2005 33 : 1402 1416.